Skip to content
← Full study record

NCT00667342 · OUTCOME

Difference Between Good and Poor Response by SUVmax

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma · Source last updated 2023-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
(unitless)
Interval / dispersion
Standard Error
Time frame
at week 10 after start of therapy

What was measured

The response is based on the Huvos grade of histologic response for DCE-MRI comparisons and is defined as good for ≥90% necrosis and poor for less than 90%.

Analysis population: One participant with no histologic response but with evaluable imaging was excluded.

Groups in this outcome

All Participants

Thirty-two participants with osteosarcoma were evaluated in this study. The analysis for this outcome measure included 23 Stratum A participants who had primary tumors potentially resectable by aggressive surgery, such as limb-salvage surgery or amputation, and no evidence of metastasis, and 8 Stratum C participants who had metastatic tumors.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Participants31

Reported measurements

Poor Response
Values in (unitless) · Interval/dispersion: Standard Error
GroupValueSpreadLowerUpperComment
All Participants6.28940.9303Not reportedNot reportedNot reported
Good Response
Values in (unitless) · Interval/dispersion: Standard Error
GroupValueSpreadLowerUpperComment
All Participants3.27200.3814Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        0.9303
        value
        6.2894
    title
    Poor Response
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        0.3814
        value
        3.2720
    title
    Good Response
denoms
  1. counts
    1. group Id
      OG000
      value
      31
    units
    Participants
description
The response is based on the Huvos grade of histologic response for DCE-MRI comparisons and is defined as good for ≥90% necrosis and poor for less than 90%.
dispersion Type
Standard Error
groups
  1. description
    Thirty-two participants with osteosarcoma were evaluated in this study. The analysis for this outcome measure included 23 Stratum A participants who had primary tumors potentially resectable by aggressive surgery, such as limb-salvage surgery or amputation, and no evidence of metastasis, and 8 Stratum C participants who had metastatic tumors.
    id
    OG000
    title
    All Participants
param Type
MEAN
population Description
One participant with no histologic response but with evaluable imaging was excluded.
reporting Status
POSTED
time Frame
at week 10 after start of therapy
title
Difference Between Good and Poor Response by SUVmax
type
SECONDARY
unit Of Measure
(unitless)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice